Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01990209
Title Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors SCRI Development Innovations, LLC
Indications

estrogen-receptor positive breast cancer

breast cancer

progesterone-receptor positive breast cancer

triple-receptor negative breast cancer

Therapies

Orteronel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.